Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam vs naproxen for pain and trismus after mandibular third molar surgery
IRCT20240109060656N3Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of meloxicam and naproxen in Impacted lower third molar, postoperative pain and trismus (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Postoperative pain intensity and Postoperative trismus. Started Jul 2025; status: completed.
02
Drugs
meloxicamnaproxen
03
Conditions
Impacted lower third molarpostoperative paintrismus
Beyond the preview
Go deeper on IRCT20240109060656N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240109060656N3.